Dis-Chem Pharmacies (DCP) Stock Overview
Engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
DCP Community Fair Values
Create NarrativeSee what 12 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Dis-Chem Pharmacies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R29.85 |
| 52 Week High | R39.00 |
| 52 Week Low | R29.63 |
| Beta | 0.29 |
| 1 Month Change | -9.71% |
| 3 Month Change | -18.22% |
| 1 Year Change | -3.86% |
| 3 Year Change | 16.15% |
| 5 Year Change | -4.45% |
| Change since IPO | 38.97% |
Recent News & Updates
Narrative Update • Jul 06
DCP: Dividend Reset And Margin Outlook Will Support Future Upside
Analysts have trimmed their price target for Dis-Chem Pharmacies to ZAR43.10 from ZAR46.20, citing updated assumptions for revenue growth, profit margins, and a slightly lower forward P/E multiple despite a reduced discount rate. What’s in the News for Dis-Chem Pharmacies Dis-Chem Pharmacies declared a gross final cash dividend of 15.91872 cents per share for the period ended 28 February 2026, aligned with its policy of paying out 40% of headline earnings.
Narrative Update • Jun 22
DCP: Reduced Dividend Payout Will Pressure Future Shareholder Returns
Analysts have nudged their fair value estimate for Dis-Chem Pharmacies slightly higher, moving the price target from ZAR27.00 to about ZAR27.75. This reflects refreshed assumptions on revenue growth, profit margins and future P/E levels.Recent updates
Narrative Update • Jul 06
DCP: Dividend Reset And Margin Outlook Will Support Future Upside
Analysts have trimmed their price target for Dis-Chem Pharmacies to ZAR43.10 from ZAR46.20, citing updated assumptions for revenue growth, profit margins, and a slightly lower forward P/E multiple despite a reduced discount rate. What’s in the News for Dis-Chem Pharmacies Dis-Chem Pharmacies declared a gross final cash dividend of 15.91872 cents per share for the period ended 28 February 2026, aligned with its policy of paying out 40% of headline earnings.Narrative Update • Jun 22
DCP: Reduced Dividend Payout Will Pressure Future Shareholder Returns
Analysts have nudged their fair value estimate for Dis-Chem Pharmacies slightly higher, moving the price target from ZAR27.00 to about ZAR27.75. This reflects refreshed assumptions on revenue growth, profit margins and future P/E levels.Narrative Update • Jun 08
DCP: Lower Dividend Payout And Weaker Margins Will Pressure Future Returns
Analysts have trimmed their ZAR price target for Dis-Chem Pharmacies from ZAR29.00 to ZAR27.00, reflecting updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Dis-Chem Pharmacies declared a gross final cash dividend of 15.91872 cents per share for the period ended 28 February 2026, in line with its stated policy of paying out 40% of headline earnings.Analysis Article • Apr 07
Here's Why We Think Dis-Chem Pharmacies (JSE:DCP) Is Well Worth Watching
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Analysis Article • Feb 13
Why You Should Care About Dis-Chem Pharmacies' (JSE:DCP) Strong Returns On Capital
To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...Analysis Article • Nov 22
Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Nov 07
Dis-Chem Pharmacies (JSE:DCP) Is Paying Out A Larger Dividend Than Last Year
Dis-Chem Pharmacies Limited ( JSE:DCP ) has announced that it will be increasing its dividend from last year's...Analysis Article • Oct 23
Pinning Down Dis-Chem Pharmacies Limited's (JSE:DCP) P/E Is Difficult Right Now
When close to half the companies in South Africa have price-to-earnings ratios (or "P/E's") below 9x, you may consider...Analysis Article • Sep 05
Dis-Chem Pharmacies (JSE:DCP) Knows How To Allocate Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysis Article • Aug 14
Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly
JSE:DCP 1 Year Share Price vs Fair Value Explore Dis-Chem Pharmacies's Fair Values from the Community and select yours...Analysis Article • Jul 17
With Dis-Chem Pharmacies Limited (JSE:DCP) It Looks Like You'll Get What You Pay For
Dis-Chem Pharmacies Limited's ( JSE:DCP ) price-to-earnings (or "P/E") ratio of 22.9x might make it look like a strong...Analysis Article • May 27
Dis-Chem Pharmacies (JSE:DCP) Is Aiming To Keep Up Its Impressive Returns
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
New Narrative • Mar 13
Expanding Into Underrepresented Areas And Digital Health Will Strengthen Market Position In ZA Retail
Strategic expansion and enhanced cost management are driving revenue and net margin growth, with significant investment in new property and underrepresented areas.Analysis Article • Feb 22
Dis-Chem Pharmacies (JSE:DCP) Knows How To Allocate Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...Analysis Article • Jan 22
Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings
With a price-to-earnings (or "P/E") ratio of 28.3x Dis-Chem Pharmacies Limited ( JSE:DCP ) may be sending very bearish...Analysis Article • Nov 27
Is Dis-Chem Pharmacies (JSE:DCP) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analysis Article • Nov 10
Shareholders Are Optimistic That Dis-Chem Pharmacies (JSE:DCP) Will Multiply In Value
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...Analysis Article • Aug 21
These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analysis Article • Jun 06
Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price
When close to half the companies in South Africa have price-to-earnings ratios (or "P/E's") below 8x, you may consider...Analysis Article • Apr 17
Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Analysis Article • Feb 26
Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Dec 30
Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysis Article • Sep 07
If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Analysis Article • Aug 16
Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Analysis Article • Jul 31
Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Analysis Article • May 09
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Analysis Article • Mar 29
There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysis Article • Jan 14
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Analysis Article • Nov 04
Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...Analysis Article • Oct 04
Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate
In this article we are going to estimate the intrinsic value of Dis-Chem Pharmacies Limited ( JSE:DCP ) by taking the...Analysis Article • Sep 01
We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Analysis Article • Jul 04
Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...Analysis Article • Jun 21
A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)
How far off is Dis-Chem Pharmacies Limited ( JSE:DCP ) from its intrinsic value? Using the most recent financial data...Analysis Article • Jun 08
Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Shareholder Returns
| DCP | ZA Consumer Retailing | ZA Market | |
|---|---|---|---|
| 7D | -7.3% | -1.0% | -1.2% |
| 1Y | -3.9% | -9.3% | 8.5% |
Return vs Industry: DCP exceeded the ZA Consumer Retailing industry which returned -9.3% over the past year.
Return vs Market: DCP underperformed the ZA Market which returned 8.5% over the past year.
Price Volatility
| DCP volatility | |
|---|---|
| DCP Average Weekly Movement | 4.5% |
| Consumer Retailing Industry Average Movement | 4.2% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in ZA Market | 9.7% |
| 10% least volatile stocks in ZA Market | 2.6% |
Stable Share Price: DCP has not had significant price volatility in the past 3 months compared to the ZA market.
Volatility Over Time: DCP's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | n/a | Rui Morais | dischemgroup.com |
Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments: Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensaries, personal care and beauty, healthcare and nutrition, baby care, and other products.
Dis-Chem Pharmacies Limited Fundamentals Summary
| DCP fundamental statistics | |
|---|---|
| Market cap | R25.55b |
| Earnings (TTM) | R978.89m |
| Revenue (TTM) | R42.83b |
26.1x
P/E Ratio0.6x
P/S RatioIs DCP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DCP income statement (TTM) | |
|---|---|
| Revenue | R42.83b |
| Cost of Revenue | R33.42b |
| Gross Profit | R9.41b |
| Other Expenses | R8.43b |
| Earnings | R978.89m |
Last Reported Earnings
Feb 28, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.14 |
| Gross Margin | 21.97% |
| Net Profit Margin | 2.29% |
| Debt/Equity Ratio | 64.9% |
How did DCP perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yield40%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/24 01:33 |
| End of Day Share Price | 2026/07/23 00:00 |
| Earnings | 2026/02/28 |
| Annual Earnings | 2026/02/28 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dis-Chem Pharmacies Limited is covered by 13 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rendani Magalela | Absa Bank Limited |
| Daniel Dias | Arqaam Capital Research Offshore S.A.L. |
| Michael de Nobrega | Avior Capital Markets |